This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
earnings-trend: Archive
CF (CF) Up 18.1% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
CF (CF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
CFNegative Net Change MOSNegative Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Allstate (ALL) Down 4.4% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Allstate (ALL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ALLNegative Net Change KNSLNegative Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Why Is Zillow (ZG) Up 6.8% Since Last Earnings Report?
by Zacks Equity Research
Zillow (ZG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ZGNegative Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Why Is Helmerich & Payne (HP) Up 21.5% Since Last Earnings Report?
by Zacks Equity Research
Helmerich & Payne (HP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
HPNegative Net Change NBRNegative Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Envista (NVST) Up 0.8% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Envista (NVST) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
NVSTNegative Net Change NEOGPositive Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Adma Biologics (ADMA) Down 4.8% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Adma Biologics (ADMA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ADMAPositive Net Change MYGNNegative Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Kymera Therapeutics (KYMR) Up 10.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Kymera Therapeutics (KYMR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
KYMRNegative Net Change TGTXPositive Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Why Is Mirum Pharmaceuticals (MIRM) Up 6.9% Since Last Earnings Report?
by Zacks Equity Research
Mirum Pharmaceuticals (MIRM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
MIRMNegative Net Change VKTXNegative Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Fastly (FSLY) Down 6.9% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Fastly (FSLY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
FSLYNegative Net Change CCCNegative Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Honeywell Aerospace (HONA) Down 1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Honeywell Aerospace (HONA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
HONANegative Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate